Advanced search
Publication Cover
Artificial Cells, Nanomedicine, and Biotechnology
An International Journal
Volume 47, 2019 - Issue 1
Submit an article Journal homepage
2,508
Views
15
CrossRef citations to date
0
Altmetric
Research Article

GPR39 agonist TC-G 1008 promotes osteoblast differentiation and mineralization in MC3T3-E1 cells

Xingyu Chaia School of Medicine, Shandong University, Ji’nan, ChinaView further author information
,
Wencan Zhangb Department of Orthopedics, Qilu Hospital, Shandong University, Ji’nan, ChinaView further author information
,
Bingying Changc Department of Orthopedics, East Hospital of Shouguang People's Hospital, Weifang, ChinaView further author information
,
Xianli Fengd Department of Orthopedics, Shandong Tai'an Coal Mine Hospital, Tai'an, ChinaView further author information
,
Jiang Songe Department of Spine Surgery, Tengzhou Central People’s Hospital, Tengzhou, ChinaView further author information
,
Le Lib Department of Orthopedics, Qilu Hospital, Shandong University, Ji’nan, ChinaView further author information
,
Chenxiao Yub Department of Orthopedics, Qilu Hospital, Shandong University, Ji’nan, ChinaView further author information
,
Junyong Zhaof College of Physics and Electronic Sciences, Shandong Normal University, Ji’nan, ChinaView further author information
&
Haipeng Sib Department of Orthopedics, Qilu Hospital, Shandong University, Ji’nan, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 3569-3576 | Received 27 May 2019, Accepted 22 Jul 2019, Published online: 26 Aug 2019

References

  • Miller PD. Management of severe osteoporosis. Expert Opin Pharmacother. 2016;17:473–488.
  • Feng X, McDonald JM. Disorders of bone remodeling. Annu Rev Pathol. 2011;6:121–145.
  • Almalki SG, Agrawal DK. Key transcription factors in the differentiation of mesenchymal stem cells. Differentiation. 2016;92:41–51.
  • Katsimbri P. The biology of normal bone remodelling. Eur J Cancer Care. 2017;26:e12740.
  • Golub EE, Boesze-Battaglia K. The role of alkaline phosphatase in mineralization. Curr Opin Orthop. 2007;18:444–448.
  • Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. Lancet. 2011;377:1276–1287.
  • Hauser AS, Misty A, Mathias RA, et al. Trends in GPCR drug discovery: new agents, targets and indications. Nat Rev Drug Discov. 2017;16:829–842.
  • Hershfinkel M. The zinc sensing receptor, ZnR/GPR39, in health and disease. Int J Mol Sci. 2018;19:439.
  • Peukert S, Hughes R, Nunez J, et al. Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists. ACS Med Chem Lett. 2014;5:1114–1118.
  • Shimizu Y, Koyama R, Kawamoto T. Rho kinase-dependent desensitization of GPR39; a unique mechanism of GPCR downregulation. Biochem Pharmacol. 2017;140:105–114.
  • Pacheco-Pantoja EL, Ranganath LR, Gallagher JA, et al. Receptors and effects of gut hormones in three osteoblastic cell lines. BMC Physiol. 2011;11:12
  • Kim SS, Choi JM, Kim JW, et al. cAMP induces neuronal differentiation of mesenchymal stem cells via activation of extracellular signal-regulated kinase/MAPK. Neuroreport. 2005;16:1357–1361.
  • Abramovitch-Dahan C, Asraf H, Bogdanovic M, et al. Amyloid β attenuates metabotropic zinc sensing receptor, mZnR/GPR39, dependent Ca2+ , ERK1/2 and Clusterin signaling in neurons. J Neurochem. 2016;139:221–233.
  • Kanazawa I, Yamaguchi T, Yano S, et al. Activation of AMP kinase and inhibition of Rho kinase induce the mineralization of osteoblastic MC3T3-E1 cells through endothelial NOS and BMP-2 expression. Am J Physiol Endocrinol Metab. 2009;296:E139–46.
  • Młyniec K, Starowicz G, Gaweł M, et al. Potential antidepressant-like properties of the TC G-1008, a GPR39 (zinc receptor) agonist. J Affect Disord. 2016;201:179–184.
  • Sudo H, Kodama HA, Amagai Y, et al. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol. 1983;96:191–198.
  • Saura M, Tarin C, Zaragoza C. Recent insights into the implication of nitric oxide in osteoblast differentiation and proliferation during bone development. Scientific World J. 2010;10:624–632.
  • Kalyanaraman H, Schall N, Pilz RB. Nitric oxide and cyclic GMP functions in bone. Nitric Oxide. 2018;76:62–70.
  • Chen Z, Peng IC, Sun W, et al. AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633. Circ Res. 2009;104:496–505.
  • Jang WG, Kim EJ, Lee KN, et al. AMP-activated protein kinase (AMPK) positively regulates osteoblast differentiation via induction of Dlx5-dependent Runx2 expression in MC3T3E1 cells. Biochem Biophys Res Commun. 2011;404:1004–1009.
  • Jovanovic M, Schmid FN, Guterman-Ram G, et al. Perturbed bone composition and integrity with disorganized osteoblast function in zinc receptor/Gpr39-deficient mice. FASEB J. 2018;32:2507–2518.
  • Luo J, Zhou W, Zhou X, et al. Regulation of bone formation and remodeling by G-protein-coupled receptor 48. Development. 2009;136:2747–2756.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.